Venus Remedies Intrinsic Value
Venus Remedies (VENUSREM) median intrinsic value is ₹863.08 from 9 valuation models (range ₹386–₹1325), vs current price ₹1030.55 — -16.3% downside (Trading Above Median Value), margin of safety -19.4%. Also explore VENUSREM share price data to track price trends across different timeframes.
VENUSREM Valuation Methods Summary — DCF, Graham Number & P/E
Venus Remedies intrinsic value across 9 models vs current price ₹1030.55 — upside/downside and value range per method. For current market price and key ratios, visit Venus Remedies share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1325.28 | ₹1060.22 - ₹1590.34 | +28.6% | EPS: ₹60.24, Sector P/E: 22x |
| Book Value Method | asset | ₹863.08 | ₹776.77 - ₹949.39 | -16.3% | Book Value/Share: ₹431.54, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1200.00 | ₹1080.00 - ₹1320.00 | +16.4% | Revenue/Share: ₹600.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1015.38 | ₹913.84 - ₹1116.92 | -1.5% | EBITDA: ₹132.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹614.16 | ₹491.33 - ₹736.99 | -40.4% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹385.54 | ₹346.99 - ₹424.09 | -62.6% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹930.71 | ₹837.64 - ₹1023.78 | -9.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹738.46 | ₹664.61 - ₹812.31 | -28.3% | ROE: 14.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹764.79 | ₹688.31 - ₹841.27 | -25.8% | EPS: ₹60.24, BVPS: ₹431.54 |
VENUSREM Intrinsic Value vs Market Price — All Valuation Models
Venus Remedies fair value range ₹386–₹1325 vs current market price ₹1030.55 across 9 valuation models. Browse VENUSREM complete financial statements for revenue, profit, balance sheet and cash flow data.
VENUSREM Intrinsic Value Analysis — Undervalued or Overvalued?
Venus Remedies median intrinsic value ₹863.08, current price ₹1030.55 — Trading Above Median Value by 16.3%, margin of safety -19.4%.
What is the intrinsic value of VENUSREM?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Venus Remedies (VENUSREM) is ₹863.08 (median value). With the current market price of ₹1030.55, this represents a -16.3% variance from our estimated fair value.
The valuation range spans from ₹385.54 to ₹1325.28, indicating ₹385.54 - ₹1325.28.
Is VENUSREM undervalued or overvalued?
Based on our multi-method analysis, Venus Remedies (VENUSREM) appears to be trading above median value by approximately 16.3%.
VENUSREM Financial Health — Key Ratios vs Industry Benchmarks
Venus Remedies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 23.79 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.09x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
VENUSREM Cash Flow Quality — Operating & Free Cash Flow
Venus Remedies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹86 Cr | ₹48 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹37 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹37 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹41 Cr | ₹33 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹132 Cr | ₹132 Cr | Positive Free Cash Flow | 8/10 |